...
首页> 外文期刊>Journal of Clinical Microbiology >Mannitol Salt Agar-Cefoxitin Combination as a Screening Medium for Methicillin-Resistant Staphylococcus aureus
【24h】

Mannitol Salt Agar-Cefoxitin Combination as a Screening Medium for Methicillin-Resistant Staphylococcus aureus

机译:甘露醇盐琼脂-头孢西汀组合作为耐甲氧西林金黄色葡萄球菌的筛选培养基

获取原文
           

摘要

In disk diffusion tests, cefoxitin is now considered a better indicator than oxacillin for the presence of the mecA gene in Staphylococcus aureus. A logical extension of this work is the incorporation of cefoxitin into media selective for methicillin-resistant Staphylococcus aureus (MRSA). This paper describes the development and subsequent testing of mannitol salt agar containing 4 mg/liter cefoxitin with a unique collection of well-characterized MRSA strains, including low-level methicillin-resistant strains and an equal number of known mecA-negative S. aureus strains. The agar supported the growth of 96.6% of the mecA-positive strains in the collection and inhibited the growth of 100% of the mecA-negative strains. These results suggest that selective media based on cefoxitin are superior to those based on oxacillin for the detection of MRSA.
机译:在椎间盘扩散试验中,头孢西丁被认为是金黄色葡萄球菌中存在 mecA 基因的一种比奥沙西林更好的指示剂。这项工作的逻辑扩展是将头孢西丁掺入对耐甲氧西林的金黄色葡萄球菌(MRSA)选择性的培养基中。本文介绍了含有4 mg / L头孢西丁的甘露醇盐琼脂的开发和后续测试,这些甘露醇盐琼脂具有特征明确的MRSA菌株的独特集合,包括低水平耐甲氧西林的菌株和相同数量的已知 mecA S。金黄色葡萄球菌琼脂支持集合中 mecA 阳性菌株的96.6%的生长,并抑制了100%的 mecA 阴性菌株的生长。这些结果表明,基于头孢西丁的选择性培养基在检测MRSA方面优于基于奥沙西林的培养基。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号